دورية أكاديمية

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

التفاصيل البيبلوغرافية
العنوان: Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
المؤلفون: Wasel, Norman, Thaçi, Diamant, French, Lars E., Conrad, Curdin, Dutronc, Yves, Gallo, Gaia, Berggren, Lovisa, Lacour, Jean-Philippe
المساهمون: Eli Lilly and Company
المصدر: Dermatology and Therapy ; volume 10, issue 4, page 663-670 ; ISSN 2193-8210 2190-9172
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2020
مصطلحات موضوعية: Dermatology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s13555-020-00383-x
DOI: 10.1007/s13555-020-00383-x.pdf
DOI: 10.1007/s13555-020-00383-x/fulltext.html
الإتاحة: https://doi.org/10.1007/s13555-020-00383-xTest
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.9E1D0B85
قاعدة البيانات: BASE